secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2023-10-17T23:59:59+00:00
Accession:  0001104659-23-109482
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical appoints Joan Lau, PhD to board as Class II director
---------------------------------------------------------------------

- Board expands from six to seven; Dr. Lau appointed Class II director, term until 2026 annual meeting.
- Dr. Lau receives $45k annual cash retainer (pro-rated), option for 25k shares, and 25k RSUs, vesting Oct 16, 2024.
- Dr. Lau is CEO of Spirovant Sciences, partner at Militia Hill Ventures, and serves on Brandywine Realty Trust board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000110465923109482/0001104659-23-109482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000110465923109482/tm2328567d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-109482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer